Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Titel:
Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study
Auteur:
Cohen, Yael C. Magen, Hila Lavi, Noa Gatt, Moshe E. Chubar, Evgeni Horowitz, Nethanel Kreiniz, Natalia Tadmor, Tamar Trestman, Svetlana Vitkon, Roy Rouvio, Ory Shvetz, Olga Shaulov, Adir Ziv-Baran, Tomer Avivi, Irit